JPRN-UMIN000003101已完成2 期
Evaluation of efficacy of letrozole as a neoadjuvant endocrine therapy in postmenopausal patients with hormone receptor-positive breast cancer - Evaluation of efficacy of letrozole as a neoadjuvant endocrine therapy in postmenopausal patients with hormone receptor-positive breast cancer
Tohoku University Graduate School of Medicine0 个研究点目标入组 30 人开始时间: 2010年1月28日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. Synchronous or asynchrous bilateral breast cancer. 2. Patients receiving drugs having a potential influence on the status of sex hormones (hormone replacement therapy, raloxifene, etc.). (However, patients after washout for at least 8 weeks can be enrolled.) 3. Patients who are being treated of cerebral infarction at the time of the enrollment. 4. Patients with myocardial infarction or congestive heart failure at the past history, or patients who need treatment of ischemic hear disease, arryhythmia or valvular disorder. 5. Patients within 30 days after completion of treatment with the investigational drugs. 6. Patients whom doctors judged inadequate to the enrollment of this study by other reasons.
研究者
相似试验
已完成
3 期
Adjuvant Therapy for Postmenopausal Patients with Operable Breast Cancer who have Estrogen Receptor or Progesterone Receptor Positive Tumors.Tamoxifen vs. Letrozole vs. Tamoxifen followed by Letrozole vs. Letrozole followed by TamoxifeBreast CancerACTRN12607000012471ovartis Pharma AG, Basel6,193
已完成
不适用
A Phase III Study to Evaluate Letrozole as Adjuvant Endocrina Therapy for Postmenopausal Women with Receptor (ER and/or PgR) Positive Tumors-C509 Breast, unspecifiedBreast, unspecifiedC509PER-051-00OVARTIS BIOSCIENSES PERU S.A.,
暂停
2 期
Study of neoadjuvant Letrozole combined with standerd chemotherapy for postmenopausal women with Endocrine-responsive Breast Cancer(subject of stage2,3A)Postmenopausal, hormone-receptor positive and resectable primary breast cancerJPRN-UMIN000002447iigata Cancer Center Hospital80
已完成
2 期
Evaluation of the usefulness of letrozole as neoadjuvant hormone therapy for postmenopausal patients with hormone receptor-positive breast cancerBreast cancerJPRN-UMIN000003699St. Luke's International Hospital60
招募中
3 期
Evaluation of the effect of hormone therapy in breast cancer before surgeryBreast cancer.Malignant neoplasm of breast, endocrine therapy, neoadjuvantIRCT20181224042091N1Mashhad University of Medical Sciences48